HAEMONETICS CORP — Director's Dealing 2024

May 8, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2024-05-06

Reporting Person: Lingamneni Anila (EVP, Chief Technology Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-06	Common Stock	S	2305	$95.00	Disposed	12295	Direct

Footnotes

F1: Transaction pursuant to an existing 10b5-1 trading plan dated June 2, 2023 (fully executed as of June 5, 2023).

F2: This number includes unvested restricted stock units previously reported as well as 289 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2024.